Expression of the proto-oncogene c-myc stimulates cell proliferation in the presence of the appropriate survival factors and triggers apoptosis in their absence; this dual capacity ensures that cell growth is restricted to the correct paracrine environment and is thereby strictly controlled. Recently our laboratory demonstrated that cMyc-induced apoptosis requires the CD95 death receptor pathway and that insulin-like growth factor (IGF-1) signalling suppresses this killing. To investigate further the links between c-Myc and IGF-1 pathways in CD95-induced apoptosis, we examined the eects of c-Myc and a downstream IGF-1 survival kinase, Akt, on killing mediated by CD95 and its recruited eector proteins (FADD and caspase-8). Here, we show that c-Myc activation does not exacerbate killing induced by FADD or pro-caspase-8, which narrows the point at which cMyc exerts its action downstream of the interaction of CD95 with its ligand and upstream of FADD. We show further that activated Akt suppresses CD95-induced apoptosis and that Akt exerts its activity at a point downstream of FADD but upstream of caspase-8. These results restrict the possible mechanisms by which CD95-induced apoptosis is modulated by death signals and survival factors.
Introduction
The proto-oncogene c-myc encodes a protein (c-Myc) belonging to the bHLH family of transcriptional regulators. In many cell types, such as ®broblasts, cMyc protein function is both necessary and sucient for cell proliferation, and its expression in normal cells is tightly regulated by the availability of mitogens (reviewed in Evan and Littlewood, 1993) . However, another intrinsic function of c-Myc is to induce apoptosis under certain circumstances, an activity thought to be important in restraining neoplastic outgrowth and in maintaining normal cellularity (reviewed in Hueber and Evan, 1998) . Mutational analyses suggest that the transcriptional regulatory activity of c-Myc is absolutely required for the induction of both proliferation and apoptosis (Amati et al., 1992 (Amati et al., , 1993 Evan et al., 1992) , although the precise molecular mechanism by which c-Myc exerts its antagonistic eects remains unknown.
A critical determinant of the ability of c-Myc to induce proliferation versus apoptosis is the availability of survival factors. Thus, ®broblasts over-expressing cMyc survive and proliferate in the presence of certain soluble cytokines such as insulin-like growth factor (IGF-1), but undergo apoptosis in their absence Harrington et al., 1994) . Recently, we demonstrated that activation of phosphatidylinositol 3-kinase (PI3-K), a downstream eector of the IGF-I receptor, suppresses c-myc-induced apoptosis through activation of the serine/threonine kinase Akt (PKB/ RAC-PK) (Kaumann-Zeh et al., 1997) . Akt (Bellacosa et al., 1991; Coer and Woodgett, 1991; Jones et al., 1991 ) is a proto-oncogene that was initially identi®ed as a retrovirally-transduced oncogene (v-akt) involved in a mouse thymic lymphoma (Bellacosa et al., 1991) . Moreover, the closely related akt2 gene is ampli®ed in certain human carcinomas (Bellacosa et al., 1995; Cheng et al., 1996) . While the signalling cascade upstream of Akt is fairly wellcharacterized, the downstream target(s) responsible for the survival eect of Akt are less well understood. Recent reports have implicated the Bcl-2 family member BAD as one target of Akt survival signalling in primary neurons and hematopoietic cells (Datta et al., 1997; del Peso et al., 1997) . However, the universality of the BAD pathway in other cell types has yet to be determined and evidence exists that Akt also has other survival targets (e.g., Datta et al., 1997; Scheid and Duronio, 1998; Yang et al., 1995) .
We recently showed that c-myc-induced killing requires the CD95 (APO1/Fas) death machinery (Hueber et al., 1997) . Speci®cally, inhibition of CD95 ligation, or of the CD95-recruited adaptor protein FADD, substantially suppresses c-Myc-induced apoptosis. Consistent with these results, c-myc killing is compromised in ®broblasts derived from lpr (Wantanabe-Fukunaga et al., 1992) or gld (Takahashi et al., 1994) mice that bear genetic lesions in genes encoding the CD95 receptor and ligand, respectively (Hueber et al., 1997) . Moreover, over-expression of c-Myc exacerbates CD95-induced killing. In addition, IGF-1 suppresses CD95-induced apoptosis, indicating that the IGF-1 survival signalling pathway acts downstream of CD95 ligation (Hueber et al., 1997) . Taken together, these results suggest that ligation of CD95 by exogenous or endogenous ligand is not necessarily sucient for cell death; rather, at least in cells of mesenchymal origin, c-Myc expression and survival factor signalling are critical determinants of the ecacy with which the CD95 signal engages the basal apoptotic machinery of the cell.
In the current study, we explored the interplay among the c-Myc, CD95 and Akt pathways. We show that c-Myc cannot potentiate killing induced by overexpression of FADD or pro-caspase-8/FLICE. This result suggests that FADD does not propagate the death signal utilized by c-Myc. Furthermore, we show that both CD95 killing and FADD-induced apoptosis are suppressed by activated Akt, whereas apoptosis induced by expression of activated caspase-8 is not. These data narrow down the window of c-Myc activation and IGF-1 inhibition to a relatively restricted set of CD95 eectors that act early on after engagement of CD95 by its ligand.
Results

c-Myc activation does not exacerbate FADD-or pro-caspase-8-induced apoptosis
The Rat-1 ®broblast cell line is normally resistant to killing by soluble CD95 ligand but becomes sensitive following c-Myc over-expression (Hueber et al., 1997) . This sensitization occurs downstream of CD95 ligation, although the mechanism is unknown. Rat-1 cells therefore present a useful model system in which to investigate c-Myc sensitization to apoptosis. To this end, we employed a transient co-transfection strategy in Rat-1/mycER TM cells in which c-Myc activity is rapidly activated by the addition of 4-hydroxytamoxifen (4-OHT) to the medium (Littlewood et al., 1995) .
After the engagement of CD95 with its ligand, the protein adaptor FADD is recruited to the cytoplasmic portion of CD95 (Boldin et al., 1995; Chinnaiyan et al., 1995) ; subsequently, pro-caspase-8 (Boldin et al., 1996; Fernandes-Alnemri et al., 1996; Muzio et al., 1996) is recruited into this death-inducing signalling complex (DISC) (reviewed in Nagata, 1997) . Our previous results demonstrated that the interaction of CD95 with its ligand is necessary for c-Myc killing (Hueber et al., 1997) ; in the current study, we wished to identify which components of the CD95 machinery are involved. Cells were transiently co-transfected with a lacZ reporter plasmid, along with constructs encoding FADD, pro-caspase-8, or the empty vector PCDNA3. Five hours later the cells were washed and medium either containing or lacking 4-OHT was added. Additionally, to ensure that CD95-induced killing after c-Myc activation was actually possible under the conditions of the assay, parallel wells of cells were transfected with the empty vector, treated with 4-OHT, then either given a dose of soluble CD95 ligand or medium alone. The following day, cells were ®xed, stained with X-gal, and lacZ-positive transfected cells were scored for apoptotic phenotype. Western blot analysis of parallel transfections con®rmed that both FADD and pro-caspase-8 were expressed during the time-frame of the assay (data not shown). Figure 1 shows a representative result of such a study. Whereas both FADD and pro-caspase-8 induce signi®cant death compared to the empty vector (56.9%+2.4 and 65.1%+0.8, respectively, versus 27.4+1.3), there is no statistically signi®cant difference in the degree of cell death after the addition of 4-OHT. In contrast, cells treated with soluble CD95 ligand, as shown previously (Hueber et al., 1997) , are killed signi®cantly more eectively if c-Myc has been activated with 4-OHT (45.5%+0.6 vs 28.5%+1.2; P50.0005). Thus, the activation of c-Myc is not sucient to exacerbate either ectopically expressed FADD-or pro-caspase-8-induced killing under the same conditions in which it can accelerate CD95L-induced apoptosis.
Akt suppresses CD95-mediated apoptosis
Given that c-Myc-induced apoptosis is both suppressed by activated Akt (Kaumann-Zeh et al., 1997) and requires the CD95 pathway (Hueber et al., 1997) , we wished to determine whether Akt expression could also inhibit apoptosis induced by directly activating the CD95 pathway, for example by stimulation with a CD95-activating antibody. To this end, we chose Swiss 3T3 ®broblasts, which are succeptible to CD95-induced killing. Using stable infection with retrovirus vectors, clones (designated S3T3/gagAkt) were derived that expressed gagAkt protein, as determined by immunoblotting (Figure 2a) , and which exhibited elevated TM cells were transiently co-transfected with a CMV-driven lacZ reporter plasmid in conjunction with constructs encoding FADD, procaspase-8 (Casp-8) or empty vector (Vec) using SuperFect reagent. After washing away complexes, the cells were incubated for 1 day with medium (2% FBS) containing (black bars) or lacking (shaded bars) 100 nM 4-hydroxytamoxifen, which induces the activity of MycER TM . Cells were then ®xed with 4% paraformaldehyde, stained for lacZ activity, and blue cells were scored blindly for apoptotic death by morphological criteria under phase contrast microscopy. Each column indicates the mean percentage of apoptotic cells from triplicate wells with approximately 500 blues cells scored per well; bars indicate the standard error of the mean, and this graph is a representative result of more than six experiments. In parallel (left-hand side), triplicate wells co-transfected with the reporter plasmid and the empty vector were treated the same as above, except that soluble CD95 ligand (sCD95L, 50 ng/ml) was included in the medium after washing intrinsic Akt kinase activity (Figure 2b ) when compared to cell lines harbouring only empty vector (designated S3T3/Vec), even in the absence of serum stimulation. To ensure that these cell lines retained normal and similar levels of CD95 receptor, we compared anti-CD95 surface staining of two dierent single-cell-derived S3T3/Akt cell lines with two dierent S3T3/Vec cell lines by¯ow cytometry ( Figure 2c ). No signi®cant dierences in CD95 surface expression were detected among any of the cells lines.
To determine whether constitutively activated Akt suppresses apoptosis induced by the CD95 agonist antibody Jo2, S3T3/gagAkt and S3T3/Vec cells were serum-deprived for 48 h. Removing serum served to inactivate endogenous Akt signalling, thus allowing us to study only the eects of the stably expressed activated Akt. Subsequently, the cells were treated either with the antibody or medium alone, then examined by time-lapse videomicroscopy ( Figure 3a ). S3T3/Vec cells were rapidly killed upon CD95 activation, with nearly all cells having succumbed after only 10 h. In contrast, S3T3/gagAkt cell death was substantially delayed. Indeed, a signi®cant population of S3T3/gagAkt cell was still alive after 6 days (data not shown). This dramatic protection from CD95-induced death was evident notwithstanding the slightly increased background apoptosis that S3T3/ gagAkt cells tend to show in the absence of serum ( Figure 3a , no antibody treatment). Akt protection was con®rmed in multiple S3T3/gagAkt clonal cell lines using several dierent assays for cell death (data not shown).
To explore further the mechanisms by which Akt protects against CD95 killing, we conducted similar experiments in the presence of 10% serum, conditions under which endogenous IGF-14PI3-K4Akt signalling pathways, as well as those downstream of other survival factors such as insulin and platelet-derived growth factor, should be fully activated ( Figure 3b ). Although serum itself can delay 3T3/Vec cell death induced by the Jo2 agonist antibody, S3T3/gagAkt cells nonetheless show increased protection, implying that constitutively activated Akt can deliver a more ecient survival signal than can full serum.
One indirect downstream target of Akt is p70 S6 kinase ( p70 S6K ) (Chung et al., 1992) . To determine whether p70 S6K is involved in Akt-mediated suppression of CD95-induced killing, time-lapse videomicroscopy was conducted on serum-deprived, agonist-antibodytreated S3T3/gagAkt or S3T3/Vec cells in the presence or absence of the p70 S6K inhibitor rapamycin ( Figure  3c ). However, rapamycin neither aected CD95-induced killing nor inhibited Akt protection from this killing, indicating that p70 S6K is not involved in suppression of apoptosis by Akt in ®broblasts.
Akt suppresses FADD-induced apoptosis but not pro-caspase-8-induced apoptosis
Our data show that c-Myc and Akt signalling intersects at a common death pathway, i.e. that downstream of CD95. We therefore wished to determine whether these opposing signals intersected at a common point in this pathway. To explore this issue, we employed a Figure 2 Swiss 3T3 cell lines harbouring activated Akt maintain stable protein expression, have enhanced Akt kinase activity, and have unaected levels of CD95 surface expression. Swiss 3T3 ®broblasts were infected with retroviruses bearing either pBN-gagAkt or the empty pBABE vector; cell lines were derived from infected single-cell-derived clones and designated S3T3/gagAkt or S3T3/ Vec, respectively. (a) Western blot analysis of equally-loaded protein lysates of the stable cell lines, immunoprobed with anti-rat Akt. Arrows indicate the positions of endogenous and gagAkt proteins. Note that as the endogenous Akt and the gag fusion Akt are derived from dierent species, the antibody may have reacted with dierential anity, so direct comparisons of the relative amounts of each should not be made. (b) In vitro Akt kinase activity assay of equal amounts of lysates from serum-deprived stable cell line protein lysates, immunoprecipitated with anti-rat Akt, and using puri®ed histone 2B (H2B) as a phosphorylation substrate (arrow). (c) Flow cytometric analysis of two dierent pairs of independent S3T3/gagAkt or S3T3/Vec clonal cell line stained with hamster anti-mouse CD95 (Jo2) (primary) and anti-hamster IgG-FITC (secondary) (overlapping curves A representative experiment is presented in Figure 4 . First, we evaluated survival from FADD-induced apoptosis. In the absence of serum (Figure 4a ), constitutively activated Akt, which was strongly detectable by Western blot in parallel transfections (data not shown), signi®cantly and reproducibly reduced the amount of apoptosis induced by cotransfection of FADD (51.7%+1.5 vs 35.8%+2.2, respectively; P50.0025). However, the kinase-inactive mutant had no signi®cant survival eect, indicating that catalytic activity of the activated Akt mutant is required for its ability to protect from FADD-induced killing. In the same experiment, parallel transfections were performed in the presence of 10% serum ( Figure  4b ). Under these conditions, apoptosis induced by FADD alone was reduced compared to the amount of death observed in the absence of serum (37.7%+1.3 vs 51.7%+1.5; P50.001); in fact, this reduced death was similar to that induced by activated Akt in the absence of serum (4a vs 4b). This result is consistent with the hypothesis that serum-induced IGF-14PI3-K4Akt survival pathways suppress FADD-induced killing. Moreover, co-transfection of the dominant negative pSG5-PKB-CAAX construct was able to antagonize signi®cantly the survival signals imparted by serum (55%+0.9% vs 37.7%+1.3; P50.0005), which is a further indication that serum-induced protection from FADD killing is dependent upon endogenous Akt. Finally, in the presence of serum, constitutively activated Akt further reduced the amount of FADD killing (37.7%+1.3 vs 26.0+0.7; P50.005), again demonstrating that activated Akt is able to provide a stronger survival signal that serum alone. Taken together, these results demonstrate that Akt can suppress FADD-induced apoptosis.
Next, we examined survival from apoptosis induced by pro-caspase-8. As depicted in Figure 4c , the constitutively activated form of Akt was unable to prevent pro-caspase-8-induced apoptosis. This result was observed in the same experiments in which activated Akt reduced FADD killing. Taken together, these data are most consistent with a model whereby Akt acts upstream of pro-caspase-8 and downstream of FADD, suggesting that c-Myc and Akt act at dierent points in the CD95 death pathway.
Discussion
The`Dual Signal' model (Harrington et al., 1994) , reviewed in holds that c-Myc simultaneously promotes proliferation and apoptosis, probably through modulation of appropriate target genes. Thus, for cells to propagate (i.e. proliferate and survive), apoptosis must be actively suppressed by survival factors, such as IGF-1 (Harrington et al., 1994) . Thus, the deregulated proliferation of cells bearing genetic lesions in growth control genes would cause these cells to outgrow their paracrine trophic environment, hence triggering apoptosis and consequent elimination of the aected clone. Such innate coupling of proliferation and cell death is presumed to act as a`fail-safe' to protect multicellular, long-lived organisms from cancer. Given the near ubiquitousness of c-Myc deregulation in human cancer (Field and Spandidos, 1990; Spencer and Groudine, 1991) , it is of obvious importance to determine exactly how c-Myc promotes cell death and how survival factor signalling suppresses it. Having recently established a critical role for the CD95 death signalling pathway in c-Myc induced apoptosis (Hueber et al., 1997) , we sought to determine at what points in the CD95 signalling cascade c-Myc and IGF-1 exert their antagonistic eects. Our data suggest that both c-Myc and the IGF-1-downstream kinase Akt ultimately impinge upon targets in the CD95 pathway, although these precise targets dier in each case.
In this report, we show that ectopic expression of either FADD or pro-caspase-8 induces apoptosis in Rat-1MycER TM cells. However, in neither case does activation of c-Myc exacerbate apoptosis whereas, in the same experiments, cell death induced by activation of CD95 with soluble CD95 ligand demonstrates clear augmentation by c-Myc. The inability of c-Myc to augment FADD-or pro-caspase-8-induced apoptosis indicates that c-Myc exerts its death-potentiating eects upstream of FADD, yet downstream of the ligated CD95 receptor.
Recently, it has become clear for several reasons that the`classical' view of CD95 killing as a single, linear pathway involving FADD, caspase-8 and downstream eector caspases is overly simplistic. First, CD95 signalling aects more than apoptosis: both Zornig et al., (1998) and others (Newton et al., 1998; Zhang et al., 1998) have recently demonstrated the existence of a CD95-dependent pathway, as yet uncharacterized, that modulates cell proliferation. Second, FADD is not the only protein known to bind the cytoplasmic portion of CD95; to date, two other molecules, RIP (Stanger et al., 1995) and DAXX (Yang et al., 1997 ) have also been implicated as possible CD95 adaptors. Indeed, at least two distinct death pathways have been de®ned downstream of CD95 in dierent cell types . In`type I' cells, DISC formation is rapid, leads to robust activation of caspase-8, and is insensitive to modulation by Bcl-2. In contrast, type II cells' exhibit little apparent DISC formation and consequent caspase-8 activation is suppressed by Bcl-2 and therefore probably occurs downstream of mitochondrial functions such as release of cytochrome C. It seems likely that even further complexity in death receptor pathways may emerge with continued study.
Our observation that FADD lies downstream of the pro-apoptotic sensitization engendered by c-Myc is particularly informative in light of the observations that although a dominant interfering FADD molecule (FADD DN) blocks c-Myc-induced apoptosis (Hueber et al., 1997) , genetic ablation of FADD has no eect on killing by c-Myc (Yeh et al., 1998) . The simplest explanation reconciling these apparently inconsistent observations is that FADD is not part of the death eector mechanism by which c-Myc promotes apoptosis; instead, c-Myc-induced cell death is mediated by some other eector whose interaction with the cytoplasmic tail of CD95 is perturbed by FADD DN. This putative other eector is an obvious candidate mediator for the`type II' CD95 killing pathway alluded to above, which seems not to involve assembly of the CD95/FADD/caspase-8 DISC. Exactly how c-Myc might promote apoptosis through such a novel CD95 eector pathway is unclear. It is possible that c-Myc promotes interaction between CD95 and its ligand, although this would also be expected to exacerbate CD95 killing via the FADD pathway. Alternatively, c-Myc might act to potentiate interaction between CD95 and its presumed other eector or indeed between any other downstream eectors of that pathway. One conclusion is unambiguous, however: cMyc does not sensitize cells to FADD killing; therefore, whatever c-Myc does has no in¯uence on either FADD or its downstream apoptotic eectors.
Survival factors such as IGF-I suppress c-Mycinduced apoptosis via activation of the serine/threonine kinase Akt. As CD95 signalling is required for c-Mycinduced apoptosis, we sought to determine whether the Akt signalling pathway suppresses CD95-induced killing and, if so, at what point in the CD95 signalling cascade it does so. Our results clearly show that constitutively activated Akt protects ®broblasts from both CD95-and FADD-induced apoptosis, an observation consistent with recent work (Hausler et al., 1998) showing that transient over-expression of gagAkt suppresses both CD95-and FADD-induced killing in COS7 cells. Furthermore, we demonstrate that a dominant negative Akt sensitizes cells to FADD killing further, indicating that signalling via endogenous wild type Akt plays a bona ®de physiological role in the suppression of FADD-induced apoptosis. To map more precisely at which point Akt acts to suppress CD95 killing, we tested the next known apoptotic eector downstream of FADD, pro-caspase-8, to determine whether its pro-apoptotic action also was suppressed by Akt. Our data show that activated Akt is unable to inhibit pro-caspase-8-induced apoptosis, at least in this experimental system of over-expression. Taken together, these results indicate that Akt (or one of its downstream targets) exerts its survival eects at a point downstream of FADD and upstream of procaspase-8.
How might Akt suppress FADD-induced apoptosis? Our experiments rule out two potential mechanisms for Akt-mediated suppression of CD95-induced killing. Akt activation has no measurable eect of levels of expression of surface CD95, implying that Akt does not protect by down-regulating expression of CD95. Furthermore, the p70 S6 kinase macrolide inhibitor rapamycin does not inhibit Akt protection, ruling out any role for p70 S6K in suppression of apoptosis. Our data show that Akt suppresses apoptosis induced by FADD but that Akt also suppresses apoptosis induced by c-Myc (Kaumann-Zeh et al., 1997) which, as we have shown, appears to be a FADD-independent pathway. This raises the possibility that Akt acts on a downstream apoptotic eector common to both FADD and c-Myc. Recent studies (Datta et al., 1997; del Peso et al., 1997) have implicated BAD, a negative regulator of the Bcl-2/ Bcl-X L family of proteins (Zha et al., 1996) , as a major anti-apoptotic target for Akt. Akt phosphorylates and functionally inactivates Bad, thereby allowing Bcl-2/ Bcl-X L proteins to exert their anti-apoptotic action. Bcl-2/Bcl-X L proteins are thought to act by suppressing release of intra-mitochondrial cytochrome C which, when liberated into the cytosol, activates caspase-9 (and thereafter downstream caspases) via the intermediary adaptor protein Apaf-1 (Li et al., 1997) . Indeed, both we (Hueber et al., 1997) and others (Itoh et al., 1993; Rodriguez et al., 1996) have shown that Bcl-2 proteins do suppress CD95-mediated apoptosis in certain circumstances, so Bad might seem a plausible Akt target common to both c-Myc and CD95 apoptotic pathways. However, there is no obvious molecular mechanism linking anti-apoptotic Bcl-2 family members with the classical type 1 CD95/ FADD/caspase-8 pathway. Although it has been suggested that Bcl-2 and Bcl-X L directly (Boise and Thompson, 1997) or indirectly (Chinnaiyan et al., 1997; Han et al., 1997; Ng et al., 1997; Hu et al., 1998) bind caspase-8 and so modulate its activation (Medema et al., 1998) , a recent report indicates that, in a system in which Bcl-X L eectively suppresses CD95-induced apoptosis, Bcl-X L neither interacts with caspase-8 nor inhibits its recruitment or activation (Medema et al., 1998) . This ®nding seems to leave little room for a role for Bad as an intermediary modulating activation of caspase-8 by FADD.
Arguably, a more likely explanation for the ability of Akt to suppress both FADD-dependent and -independent apoptosis is that FADD has other downstream apoptotic eectors in addition to caspase-8. Assuming Bad is the sole anti-apoptotic target for Akt, these other downstream eectors would presumably converge on the mitochondrial pathway that Bad and Bcl-2/Bcl-X L proteins modulate. However, evidence is emerging which suggests that Bad is not always the relevant Akt target for survival. In FL5.12 cells, Akt promotes apoptotic survival (Datta et al., 1997; del Peso et al., 1997) although Bcl-2 family members seem not to play a critical role in survival from apoptosis and ectopic expression of BAD does not induce apoptosis (Yang et al., 1995) . More strikingly, Scheid and colleagues (Scheid and Duronio, 1998 ) recently reported a system in which interleukin-4 (IL-4) promoted apoptotic survival and Akt activation but did not lead to Bad phosphorylation. Thus, Akt may act on other targets to suppress cell death and some of these may be alternate downstream apoptotic eectors of FADD, certain of which could share common elements with the c-Myc apoptotic pathway. Indeed, FADD is known to interact with a number of intracellular molecules, some of which are implicated in apoptosis. However, none of these has yet been shown to be a relevant target for Akt in vivo. A related possibility is that FADD is itself a direct target for Akt. It will be important in the future to identify novel targets by which Akt suppresses apoptosis and particularly interesting to see how the pathways aected by such novel targets intersect with the apoptotic programme implemented by c-Myc.
Materials and methods
Plasmids and cloning
The following constructs have been described previously: pSG5-PKBgag encodes a portion of the Moloney murine leukaemia virus (MuLV) Gag protein fused in-frame to the bovine Akt protein, a con®guration that confers a constitutively activated kinase activity (Burgering and Coer, 1995) . pSG5-PKBgag[K4A] is identical to pSG5-PKBgag except the critical catalytic lysine (K179) has been mutated to an alanine (Kaumann-Zeh et al., 1997) , rendering the encoded protein kinase-inactive. pSG5-PKB-CAAX encodes a Akt protein with dominant negative activity (van Weeren et al., 1998) . All three Akt constructs are expressed under the control of the early SV40 promoter for eukaryotic expression. PCDNA3-FADD and PCDNA3-FLICE encode human FADD and pro-caspase-8, respectively, and are expressed under the control of the cytomegalovirus (CMV) promoter for eukaryotic expression (Chinnaiyan et al., 1995; Muzio et al., 1998) . PCDNA3.1/His/lacZ (Invitrogen) encodes the Escherichia coli b-galactosidase gene under the control of the CMV promoter. Additionally, we cloned the PKBgag portion of pSG5-PKBgag into the retroviral vector pBABEneo (Morgenstern and Land, 1990) using standard methodology; the resultant construct is called pBNgagAkt.
Cell culture and cell line construction
Unless otherwise speci®ed for certain experiments, all cultures were grown in Dulbecco's minimum essential medium supplemented with 10% foetal bovine serum (FBS), 100 U/ml penicillin and 100 ug/ml streptomycin sulphate, supplemented with selective drug as appropriate. GP+E ecotropic MuLV packaging cells (Markovitz et al., 1988) were maintained in the absence of selective medium for short passages. Rat-1/MycER TM (Littlewood et al., 1995) cells that express a 4-hydroxytamoxifen (4-OHT)-activatable human c-Myc protein were maintained in 200 ug/ml puromycin. Swiss 3T3 cells stably expressing pBN-gagAkt or the empty pBabeNeo vector were isolated following retrovirus production in GP+E cells, infection, selection and cloning essentially as described previously (Littlewood et al., 1995) . Multiple single-cell-derived cell lines were screened for use by Western analysis, kinase activity, and CD95 surface expression. The resultant cell lines were called S3T3/gagAkt or S3T3/Vec, and were maintained in 1 mg/ml Geneticin (Gibco).
Western blot analysis
Cells were lysed in 62.5 mM Tris HCL pH 6.8, 1% SDS, 10% glycerol, 5% 2-mercaptoethanol plus protease inhibitors, clari®ed by centrifugation, and the supernatants quantitated (D C Assay, Biorad). Lysates were fractionated by SDS ± PAGE analysis using 7.5% polyacrylamide. Proteins were electroblotted onto Immobilon-P ®lters, then blocked in 5% nonfat dry milk, 0.5% Tween-20 in PBS. Immunostaining and washes were carried out in TBS-T (tris-buered saline and 0.5% Tween-20). The primary antibody (1 : 1000 dilution, supplemented with 1.0% BSA) was anti-rat Akt rabbit polyclonal (Upstate Biotechnology), and the secondary antibody (1 : 2000 dilution) was HRP-conjugated anti-rabbit IgG (Amersham). Proteins were detected using enhanced chemiluminescence (ECL) (Amersham) using the manufacturer's protocol.
In vitro Akt kinase activity assay
This assay was performed essentially as described previously (Burgering and Coer, 1995; Kaumann-Zeh et al., 1997) . Brie¯y, gagAkt proteins were immunoprecipitated with polyclonal anti-rat Akt antibody (Upstate Biotechnology) and assayed for in vitro phosphorylation of puri®ed histone 2B (Boehringer Mannheim). Radioactively labelled substrate was resolved by SDS ± PAGE and detected by autoradiography.
Flow cytometric analysis for CD95 surface expression
Various S3T3/Akt and S3T3/Vec cell lines were analysed for surface expression of CD95 receptor with the hamster anti-CD95 monoclonal antibody Jo2 (Pharmingen) as described previously (Hueber et al., 1997) .
Transient transfection apoptosis assay
Rat-1/mycER TM cells were seeded in 6-well plates (10 5 well) and the next day were transiently transfected with DNA using the SuperFect method (Qiagen). Transfection complex mixtures contained a total of 7 ug of DNA and were distributed evenly onto triplicate wells (2.3 ug/well). In cases where multiple DNAs were used, the total amount of DNA was kept constant at 7 ug using relevant empty vector DNA; for three-way co-transfections, the following amounts were used: reporter plasmid (PCDNA3.1/His/ lacZ) (0.7 ug),`killer' plasmid (PCDNA3-FADD, PCDNA3-FLICE) (2 ug), and Akt mutant plasmid (pSG5-PKBgag, pSG5-PKBgag[K4A], pSG5-PKB-CAAX) (4.3 ug). For two-way co-transfections, 0.7 ug of reporter and 6.3 ug of`killer' plasmids were used. Five hours PT, cells were washed three times in PBS then supplied with the appropriate medium (with varying FBS concentrations and sometimes with the addition of 4-OHT [100 nM ®nal concentration] to induce c-Myc activity, or soluble CD95 ligand [sCD95L, Alexis, 50 ng/ml ®nal concentration]). Eighteen to thirty hours PT, cells were washed in PBS, ®xed in 4% paraformaldehyde in PBS for 5 ± 10 min, washed again, and stained with 16PBS, 2 mM MgCl 2 , 5 mM K 3 (CN) 6 FC, 5 mM K 4 (CN) 6 FC, and X-gal (1 mg/ml) overnight at 378C. During washing and staining, plates were centrifuged at 1500 r.p.m. prior to supernatant removal, and removal was performed slowly and carefully with low vaccuum to maximize recovery of¯oating cells. Using phase-constract microscopy, approximately 500 randomly chosen lacZ-positive cells per well were scored for apoptotic morphology (a rounded, condensed appearance). To ensure that the presented dierences in mean apoptosis were statistically signi®cant, Student's t-test was performed.
CD95 agonist survival assays S3T3/gagAkt or S3T3/Vec were either cultured in 10% serum or serum-deprived for 48 h, then treated with 100 ng/ml of the CD95 agonist antibody Jo2 (Pharmingen). When rapamycin (Calbiochem) was used, it was added 10 min prior to the death stimulus at a concentration of 20 ng/ml. Apoptosis was scored using time-lapse videomicroscopy of 100 randomly chosen cells as described previously (Hueber et al., 1997) . Apoptosis was also con®rmed by propidium iodide/¯ow cytometric analysis for sub-G1 DNA content as well as by the MTT assay (Hueber et al., 1997) . To ensure that eects seen were not merely due to clonal variation, survival was con®rmed in multiple S3T3/gagAkt cell lines.
